| Regenerative and Functional Medicine Conference 2012 |
| Regenerative Medicine-2012 is a remarkable event which brings together a unique and international mixture of large and medium pharmaceutical, health care, food technology, biotech & diagnostic companies, few of the research institutes to most of the leading universities. |
| OMICS Group invites all the participants across the globe to attend the International Conference on Regenerative & Functional Medicine during November 12-14, 2012 at Hilton San Antonio Airport, San Antonio, USA. Regenerative Medicine-2012 is a remarkable event which brings together a unique and international mixture of large and medium pharmaceutical, health care, food technology, biotech & diagnostic companies, few of the research institutes to most of the leading universities; making the congress a perfect platform to share, experience, foster collaborations across industry & academia and evaluate emerging technology/engineering across the globe. Track 1: Latest Developments in Stem Cell Research and Regenerative Medicine Track 1-1 Potential of embryonic stem cells for invivo bone regeneration Track 1-2 Mesenchymal stem cells for vascular regeneration Track 1-3 Role of extracellular factors in axon regeneration in CNS-Implications for therapy Track 1-4 Disease responsive neural precursor cells are present in multiple sclerosis lesions Track 1-5 Using stem cells and reprogramming to understand disease Track 2: Biomaterials in Tissue Engineering Track 2-1 Scaffolds of biomaterials in tissue engineering Track 2-2 Biopolymeric tissue engineering in oncology Track 2-3 Cells and biomaterials for intervertebral disc regeneration Track 2-4 Tendon, cartilage and ligament engineering Track 2-5 Nanobiomaterials for guided tissue regeneration Track 3: Advances in Gene Therapy Track 3-1 Human gene therapy (human genome project) genetic screening and DNA test Track 3-2 Viral vectors and gene therapy Track 3-3 Development in cell cloning Track 3-4 Gene therapy- somatic and germline Track 3-5 Employing the genome in regeneration medicine: ZFP targeted genome engineering Track 4: Novel Methods in Regenerative Medicine Track 4-1 Human myoblast-Genome therapy for regenerative medicine Track 4-2 Stem cells vs artificial cells in regenerative medicine Track 4-3 New frontiers in angiogenesis and tissue engineering Track 4-4 Molecular and personalized diagnostics Track 4-5 Recent approaches in cancer molecular markers and medicine Track 4-6 Biomarkers for early detection of post-transplantation rejection Track 5: Molecular Therapy Track 5-1 Novel anticoagulant therapy Track 5-2 Bridging therapy Track 5-3 RNA therapeutics Track 5-4 The future potential of immunotherapies Track 5-5 Cell tracking and imaging Track 6: Research Trend in Regenerative Medicine Track 6-1 Liver, lung, kidney regeneration Track 6-2 Nerve and spinalcord regeneration Track 6-3 Anti-inflammation and tissue regeneration Track 6-4 Skin and soft tissue regeneration Track 6-5 Prolotherapy aka regenerative injection therapy (RIT) Track 7: Ethics and Applications of Regenerative Medicine Track 7-1 Ethics (research, transplant and regenerative medicine) Track 7-2 The regulatory process and legal implications Track 7-3 Fundamentals of clinical trials design Track 7-4 Functional imaging for regenerative medicine Track 7-5 Molecular cell growth and proliferation, T- Cell biology Track 8: Anti Aging Regenerative and Functional Medicine Track 8-1 Anti-aging and metabolic approach to neurology Track 8-2 Functional approach in gastroenterology Track 8-3 Functional cardiovascular tissue regeneration Track 8-4 A metabolic anti-aging and functional approach cancer therapies Track 8-5 Stem cell therapies in anti aging and metabolic syndromes Track 8-6 Anti-oxidants as functional medicine in anti-aging and regeneration Track 9: Application of Functional Medicine in Clinical Practice Track 9-1 Hormonal imbalance including adrenal, thyroid and sex harmones Track 9-2 Polymorphisms and endocrine metabolism Track 9-3 Insulin resistance and cardiometabolic syndrome Track 9-4 Gastrointestinal dysfunction and its links to chronic diseases Track 9-5 Food sensitivities and impaired biotransformation |